IIgAN-PT Archives - NephU

+

Help Us Enhance Your NephU Experience

Help Us Enhance Your NephU Experience

User experience form

Email Address*(Required)

What is Your Specialty?*(Required)

Select all that apply (Select at least one)*

What are your goals for visiting NephU?(Required)

Learn about IgAN MOD and disease progression

Join the NephU community

Access additional IgAN resources

Select all that apply (Select at least one)*

How would you like to hear from us?(Required)

Biweekly Email Newsletters

Schedule a Meeting with a Medical Science Liaison

Learn About Upcoming Live/Virtual Events

Agree(Required)

By providing your name, email address, and other information, you are giving Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and companies working with OPDC permission to send you information from NephU. OPDC will not sell or transfer your name, address, or email address. You agree that should you use any material provided through NephU, you will attribute the source of that information to “NephU sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc.” For additional information, please read our Privacy Policy. By submitting your information, you agree to the terms provided above, and the terms provided in our Terms of Use and our Privacy Policy.

*Required Field

CAPTCHA

Risk of Progression to Kidney Failure in IgA Nephropathy

Infographic August 29, 2025

This infographic highlights the risk of progression to ESKD, including in patients traditionally considered low risk. Read More

APRIL & the 4-Hit Pathogenic Cascade of IgAN

Infographic August 29, 2025

This infographic highlights the role of APRIL in a pre-hit 1 step that drives the 4-hit cascade.1 References 1. Mathur M, et al. J Clin Med. 2023;12(21):6927. Read More

Utilization Of The International IgA Nephropathy Prediction Tool

Webinar January 29, 2025 from 12:00 pm to 1:00 pm EST

Learn about the clinical, laboratory and histological risk predictors that make up the International IgAN Prediction Tool and gain an understanding of its clinical utility and future potential. Read More

Overview of IgAN

Infographic October 7, 2024

This infographic focuses on IgAN diagnosis, prognosis, and disease management strategies. Read More

NephU Infographic – International IgA Nephropathy Prediction Tool (IIgAN-PT)

Infographic August 5, 2024

Learn about the International IgA Nephropathy Prediction Tool (IIgAN-PT), the preferred prediction tool for time of kidney biopsy. Read More

NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the kidney health community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.

May 2025 US.CORP.D.25.00000

August 2024 US.CORP.X.24.00265

©2025 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved.